ABOUT THE PRODUCT
Lead development program for a novel therapeutic targeting Type 2 Diabetes, currently in Phase 2 clinical trials.
Information is owner-confirmed
Last updated 3 weeks ago
Price range
N/A
ABOUT THE PRODUCT
Information is owner-confirmed
Last updated 3 weeks ago